PARTNERING

ALLIANCES AND PARTNERING OPPORTUNITIES

To fully exploit the potential of our platform technology we are seeking collaborations to bring forward new methods and innovative products, and unlock the true potential of certain classes of innovative medicines.

PCI Biotech’s platform technology is under development in two different areas: (1) Photochemical lysis (PCL), inducing selective light-triggered cell lysis to enhance extraction of viral vectors while reducing host-cell impurities in viral vector manufacturing. (2) Photochemical internalisation (PCI), inducing light-triggered endosomal release.

Learn more about our platform technology and development programmes under Technology

COLLABORATIONS

We commit to partners with synergistic ideas to drive progress. The main priorities are collaborations for developing the promising PCL technology for viral vector manufacturing and partnerships for locally enhanced intracellular delivery by the PCI technology for dermatological or intratumoural applications.

Where to meet us: List of all events where we are planning to attend during the current half year, with a link to the event:

• International Society for Cell and Gene Therapy (ISCT), New Orleans, USA, Annual meeting 6-10 May 2025

• American Society of Gene and Cell Therapy (ASCGT), New Orleans, USA, Annual meeting 13-17 May 2025

• LSX Nordic Congress, Bergen, Norway, 20-21 May 2025

• BIO International, Boston, USA, 16-19 June 2025

How to contact us: Partnering(at)pcibiotech.no